USC/Norris Comprehensive Cancer Center
USC/Norris
About USC/Norris
Patient Care
Research
Clinical Trials
Search Trials
Faculty
Education
Future at USC/Norris
Core Facilities
Support USC/Norris
» Contact Us
» Glossary
» Make a Donation
If you are a patient, please contact
The Doctors of USC
at 800-USC-CARE.
Details for trial 0S-00-15
Description:
Molecular Determinants of Response and Survival to Fluoropyrimidines in Patients with GI Cancer.
Status:
Open
Randomized?
No
Researchers
Principal Investigator
Title
Heinz Josef Lenz
M.D.
Data Management
Name
Title
Ramona Lujan
R.N.
Yordy Brito
D.M.
You may participate in this study if:
Requirement
1
Histologically confirmed cancer that will be treated with 5-FU-based chemotherapy.
2
At least 18 years of age.
3
Prior chemotherapy is allowed. No prior 5-FU therapy is allowed, except when patients are treated with novel fluoropyrimidine compounds (xeloda or alimpta).
4
Must allow the use of their fresh frozen or paraffin-embedded tumor tissue that has been previously collected. Tumor tissue should be collected prior to the start of fluoropyrimidine therapy.
5
Signed informed consent.
You may not participate in this study if:
1
Limited amount of tumor tissue available for diagnostic purposes. The pathologists, Drs. Sherrod and Naritoku will make the decision whether there is sufficient material for this study.
For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.
